This session will provide a landscape view on the world of deal making in the past year and evolving trends in the biopharma sector.

The speaker will highlight the deal making activities, notable deals and evolving trends as to deal activity level, impact of Covid, deal valuation, deal structure preferences, or deal types. Speaker will also highlight the evolution of what is "hot" for licensing activity. It will touch upon the potential impact of the rapidly changing environment on deal making and implications for business development strategy across the scope of the biopharma landscape

Pricing: $49